Sign in
4

Changes in Ownership

enGene Therapeutics Inc. Filed Acc 0000929638-24-001049

Options or other derivatives

  • Chief Legal Ofc. and Corp Secy acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Giguere Lee · Chief Legal Ofc. and Corp Secy

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +225,000 225,000 D
Loading xslF345X05/form4.xml…